Interestingly, imaging assessment of VCAM-1 density before treatment initiation has resulted in information about the T-cell infiltration within the tumor vasculature and about the response to PD-L1 blockade in preclinical models of colorectal cancer [38]. This evidence concerns the gene VCAM1 and neoplasm.